HAAS KEVIN

PrivateCIK: 1723780
Location

MENLO PARK, CA

HAAS KEVIN enters VINCERX PHARMA, INC. with 42.78K shares plus derivative instruments

Holding both equity and derivatives at entry signals strong long-term conviction in the company.

Direct Derivatives
InsiderHAAS KEVINCIK 1723780
IssuerVINCERX PHARMA, INC.CIK 1796129
Officer· Acting Chief Financial Officer
Since Dec 2024
42.78K
Baseline shares
100% direct
42.78K
Direct ownership
1 position
144.45K
Derivative underlying
6 instruments
1
Security positions
All direct
Non-Derivative Holdings1

Common Stock

Direct
Shares owned42.78K
Total
42.78K direct42.78K
Derivative Holdings6

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

27.88K

Shares owned

N/A

Exercise price

0.55

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

37.13K

Shares owned

N/A

Exercise price

0.55

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

19K

Shares owned

N/A

Exercise price

0.55

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

14.45K

Shares owned

N/A

Exercise price

0.55

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

19K

Shares owned

N/A

Exercise price

0.55

Expiration

Exercise window

Stock Option (right to buy)

Direct
Underlying security
Common Stock

Underlying shares

27K

Shares owned

N/A

Exercise price

0.55

Expiration

Exercise window

Total

Underlying

144.45K

Owned

0.00

HAAS KEVIN — Initial Ownership Disclosure (Form 3) Filed Jan 6, 2025 | Finecho